InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-81.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by HOLMLUND JON T, Directeur Médical. Director active across 1 company, notably Galera Therapeutics, Inc.. In total, 2 reports have been published. History available since 1 September 2021. The latest transaction was filed on 1 September 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations2 total
47,756 shares@ US$2.430.61% mcap50.0% of flowCommon StockSEC:0000899243-21-035130:0
47,756 shares@ US$2.4350.0% of flowCommon StockSEC:0000899243-21-035130
2 of 2 declarations
About HOLMLUND JON T
Jon T. Holmlund is the Chief Medical Officer at Galera Therapeutics, Inc. In this role, he is responsible for leading the company's clinical initiatives and medical strategy. With extensive expertise in the medical and pharmaceutical fields, he plays a key role in the development of innovative treatments and overseeing clinical trials. His experience contributes to Galera's commitment to improving patient outcomes.
